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Following the steps of the founders of modern red blood cell (RBC) research (e.g., Ørskov, 1935;
Wilbrandt, 1937; Cohn and Cohn, 1939; Ponder, 1948; Pauling et al., 1949), we answer to the
growing need of a platform to share and discuss the new findings, argue and move forward in
our understanding of these amazing cells. We herewith initiate a new section of the Frontiers in
Physiology dedicated to Red Blood Cell Physiology by naming some of the grand challenges in
the areas that have to be addressed in the years to come from our point of view. These are basic
problems related to our understanding of the structure and function of RBCs from a different
perspective as well as the need of new approaches and solutions in translational hematological
research.
BASIC SCIENCE
In the clinical environment we still refer to “mean red blood cell volume” MCV, mean corpuscular
hemoglobin concentration” MCHC and other “mean” values of RBC indices and characteristics
such as deformability, density and longevity and others (Brugnara and Mohandas, 2013; Da Costa
et al., 2016). We also operate with bulk responses of RBCs to stimuli comparing one “steady state”
to the new one all cells miraculously acquire at the same time in our test tubes. Does it always make
sense?
Form what we have learned about RBCs during the past decades multiple fractions of RBCs
exist in our blood having distinct properties and sensitivity to stressors. The number of these
fractions and the number of RBCs forming each of them varies between the healthy humans,
and changes strikingly in patients with different diseases. We know close to nothing about the
factors in control of this variability, only that it cannot be explained by the age of RBCs alone
(Lutz and Bogdanova, 2013; Wang et al., 2013). This gap in knowledge demands more attention of
researchers and the application of old (like density centrifugation or fluorescence based cell sorting)
and new technological approaches (like single cell high throughput technologies) allowing to obtain
readouts of subpopulations or even individual cells. Information on up to a few thousand RBCs will
give the overview of the populations of cells forming fractions.
One more fundamental problem is to define a “steady state condition” we usually refer to, and
whether it exists at all. Progress in live cell imaging revealed that RBCs are dynamic entities that
choose one of several preferred states and may be found in any of those at any point in time when
in flow. They move, Ca2+ levels in them oscillate, their ion content and pre-membrane ATP levels
fluctuate too. Very little is known about the dynamics of these processes. We already started to
farewell this snapshot-like approaches but there are still challenges to overcome.
The impact of RBC heterogeneity and its dynamic adaptive nature on blood rheology and gas
exchange remains unclear. Addressing these questions is impossible without development of new
integrative interdisciplinary experimental and theoretical modeling approaches.
A concept currently emerging, suggests that any stress conditions including acute or chronic
stimulation of de novo RBC production affect signaling pathways engaged in control of
proliferation and differentiation of erythroid precursor cells (Breda and Rivella, 2014). As a result,
newly produced RBCs may differ in properties from those circulating in organisms with unstressed
erythropoiesis. What are the mechanisms behind stress erythropoiesis and what are the properties
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of RBCs produced in response to stress as well as the role
these cells play in adaptation to environmental challenge requires
detailed investigation? Research in this area will have a vast
impact at the translational level as stress erythropoiesis is
acknowledged for patients presented with chronic hemolytic
state.
Despite decades of studies we still lack basic understanding
of the maintenance of RBC structure and function in the course
of 100–120 days RBCs spend in the circulation (Vácha, 1983).
Protein turnover in nucleated cells is typically in the range
of hours to a couple of days, far shorter life span range than
months that exact same proteins remain functional in RBCs.
This impressive longevity of cells was not studied in details.
Lacking translation, the maintenance of RBC function under the
stressful conditions in the circulation is impressive and not fully
understood (Kaestner and Minetti, 2017).
Furthermore, we would like to draw attention of researchers
and readership of a new section in Frontiers to the role of
experimental design in maintaining “physiological conditions.”
To what extent shear, plasma constituents like albumin,
amino acids and other factors that are usually neglected
in the experimental settings impact the levels of NO and
GSH production and Ca2+ signaling in RBCs is not clear.
Do hormones, inflammatory factors, temperature and CO2
availability matter for mimicking the physiologically-relevant
environment? We came to the point when standardized
meaningful experimental conditions should be adapted for the
majority of research work in order to better be able to compare
and discuss the findings obtained by different groups. These
requirements, however, should not hinder innovation. Some
sensitive points in experimental design that help to avoidmultiple
artifacts have been discussed in the past (Minetti et al., 2013).
Those include the need of leucodepletion to prevent proteolysis
that may be detected using zymography. Meanwhile it has
been shown that even zymography is not sensitive enough
to avoid “contamination” with leucocytes as next generation
sequencing of the transcriptome revealed the presence of traces of
“contaminations” with leucocytes in RBC preparations obtained
after filtration through the cellulose column (Danielczok et al.,
2017).
For a long time, comparative approach to red cell biology
was largely abandoned in the literature. As a result, all we know
about RBCs of different species dates back to the reports of mid-
to-end of twentieth century and earlier (e.g., Nikinmaa, 1990).
Information on adaptation and resistance to infections as well as
basic knowledge in comparative red cell biology may eventually
teach us how to cure diseases from the evolution perspective. This
knowledge is at least equally (if not more) valuable compared to
that obtained from transgenic animals.
Several concepts within RBC research field are still awaiting
strong experimental arguments to be proven or disapproved.
Among them are neocytolysis (Risso et al., 2014) and the role
of RBCs in systemic circadian rhythm maintenance (O’Neill and
Reddy, 2011).
TRANSLATIONAL CHALLENGES
Modern world aims to provide optimal therapy to each of
over 1.5 billion people suffering from anemia, be it caused by
mutations or malnutrition of people (de Benoist et al., 2008).
This incredible statistics stems from the lack of medical aid,
but also from the insufficient understanding of the causes of
disease and processes involved in its pathological manifestations.
Gene editing therapy and bone marrow transplantation for
treatment of patients with hereditary hemolytic anemias
such as sickle cell disease or thalassemia are the ultimate
treatments of choice. However, they are currently available
to a small number of patients in developing countries, but
not at locations where most of patients currently reside, in
Asian and African countries. Both, diagnostic methods and
therapeutic approaches for these cohorts of patients should
be affordable, reliable and robust. Novel point of care (PoC)
tests, e.g., for sickle cell disease screening or quantitative
G6PD-deficiency tests, should address the needs of the patients
in low income countries and/or in remote locations. New
supportive therapies most likely will address the symptoms, not
the mutations themselves. These therapies, as well as tests for
responsiveness of patients to the new treatments are currently
under development by translational researchers (biologists,
chemists, pharmacologists, physicists) in collaboration with
clinical hematologists and industrial experts. It’s worthwhile to
mention that the development of new technologies and tests will
include state-of-the-art informatics approaches, such as machine
learning techniques.
New methods to monitor efficacy of treatment will require
little volumes of blood and deliver information on severity of
disease based on analysis of blood fractions and individual cells.
If this works out, personalized medication in terms of drug
selection and dose might even be realized on a global level. These
new technologies and assays should become part of a standard
PoC test battery more efficient than currently available and as
mentioned above, affordable for all patients.
Transfusion research faces its revival. In addition to
improved preservation techniques, reduction of transfusion-
related complications and increase in longevity to transfused
RBCs in the circulation (Withanawasam and Wright, 2017), a
new field has emerged. Stem cells are being used as a source
of RBC cultivation in vitro (Douay and Giarratana, 2005). This
is a very challenging task for interdisciplinary teams composed
of biologists, engineers and specialists in blood banking. We
reached a stage where in vitro grown reticulocytes can be
generated in the milliliter range and currently first transfusion
trials on humans are performed. However, to scale up and
reach the level of medical transfusion volumes, the development
of bioreactors for expansion and differentiation of erythroid
precursors to reticulocytes and their maturation to RBCs are
required.
With the increasing availability of next generation sequencing
methods, an increasing number of diseases including rare
diseases can be associated with particular proteins and mutations
therein. Translational research is urgently required to explore the
link (e.g., the molecular signaling) between the mutation and
the symptoms of the patient. Although there is good progress,
even for the longest known mutation based disease, sickle cell
anemia (Pauling et al., 1949), the link between themutation in the
hemoglobin and the irregular vaso occlusive crises is not entirely
clear.
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Considering the tools that will help to tackle these challenges
we should emphasize the priority of research using human blood
samples over results obtained for the countless transgenic mouse
models. The findings obtained for these models, although useful,
cannot be directly translated to the mechanisms of RBC diseases
in humans. So, “curing mice” should not be the ultimate goal as
long as RBCs of human (and other animal) patients are neglected.
Furthermore, to understand blood flow, that is different
from Newtonian fluids and that is largely determined by the
properties of RBCs, especially the formation of turbulences in
pipe like structures will allow to capture the formation of vortices
under physiological or pathological conditions, e.g., during atrial
fibrillation (Park et al., 2013). Such questions can only be solved
on an interdisciplinary base spanning from theoretical and
experimental physics to biomedical and clinical research.
Our optimism in finding solutions to these problems relies
on the revival of the interest to RBC research, impressive
efficacy and devotion of the groups of scientists and clinical
hematologists. The European Hematological Association and
American Hematological Society, the American Red Cell
Club and the European Red Cell Society (ERCS), as well
as the European Network for Rare Congenital Anemias
(ENERCA) work together on these challenging topics. Several
European consortia receive funding from the EU to provide
a breakthrough in generation of new knowledge, development
of new technologies, studying red cell disorders and educating
young scientists in these areas. Also programs or dedicated
research institutions on the national level like the Laboratory
of Excellence (GR-Ex) in France or Sanquin Research in
The Netherlands are vital for future RBC research. We hope
that a new information exchange platform within Frontiers
in Physiology, the Red Blood Cell Physiology Section will
contribute to the intensive and fast information exchange,
promote discussions and education in red cell research.We invite
all the experts and young researchers to join this platform with
their best high quality red cell research and we promise a fair and
transparent review process.
It’s almost obvious that the RBC moves but we believe that
after passing a period of contempt at the eve of the new
millennium, RBCs are back to move biomedical science forward
again.
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